Pulmonary Arterial Hypertension Market Intelligence Report - Global Forecast to 2025

Home > Market Research Reports > Pharmaceutical

	Market Research Report Pulmonary Arterial Hypertension Market Intelligence Report - Global Forecast to 2025
Published by	360iResearch LLP			Product code	931020
Published	April 1, 2020	Content info	45 Pages Delivery time: 1-2 business days
Price	PDF (Single User License) USD 1449 PDF (Corporate User License) USD 2449 PDF (Enterprise User License) USD 3449

Description

The Global Pulmonary Arterial Hypertension Market is projected to reach USD 9,925.12 Million by 2025 from USD 7,196.48 Million in 2019, at a Compound Annual Growth Rate (CAGR) of 5.50%.

"The Prostacyclin & Prostacyclin Analog is projected to witness the highest growth during the forecast period"

On the basis of Drug Class, the Pulmonary Arterial Hypertension Market is studied across Calcium Channel Blocker, Endothelin Receptor Antagonists, Phosphodiesterase 5, and Prostacyclin & Prostacyclin Analog.

"The Online Pharmacy is projected to witness the highest growth during the forecast period"

On the basis of Distribution, the Pulmonary Arterial Hypertension Market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Table of Contents

Product Code: MIR-47B0AE5

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Market Overview

2.1. Introduction
2.2. Pulmonary Arterial Hypertension Market, By Geography
2.3. Pulmonary Arterial Hypertension Market, By Drug Class
2.4. Pulmonary Arterial Hypertension Market, By Distribution

3. Pulmonary Arterial Hypertension Market, By Drug Class

3.1. Introduction
3.2. Calcium Channel Blocker
3.3. Endothelin Receptor Antagonists
3.4. Phosphodiesterase 5
3.5. Prostacyclin & Prostacyclin Analog

4. Pulmonary Arterial Hypertension Market, By Distribution

4.1. Introduction
4.2. Hospital Pharmacy
4.3. Online Pharmacy
4.4. Retail Pharmacy

5. Appendix

5.1. Discussion Guide
5.2. Edition Details
5.3. License Details
5.4. Pricing Details

List of Figures

FIGURE 1. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 2. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 3. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DISTRIBUTION, 2019 VS 2025 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DRUG CLASS, 2025 (USD MILLION)
FIGURE 6. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY CALCIUM CHANNEL BLOCKER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 7. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY ENDOTHELIN RECEPTOR ANTAGONISTS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 8. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY PHOSPHODIESTERASE 5 SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 9. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY PROSTACYCLIN & PROSTACYCLIN ANALOG SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DISTRIBUTION, 2025 (USD MILLION)
FIGURE 11. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY HOSPITAL PHARMACY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 12. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY ONLINE PHARMACY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 13. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET, BY RETAIL PHARMACY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)

List of Tables

TABLE 1. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY ENDOTHELIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY PHOSPHODIESTERASE 5, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY PROSTACYCLIN & PROSTACYCLIN ANALOG, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY DISTRIBUTION, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: EDITION DETAILS
TABLE 13. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: LICENSE DETAILS
TABLE 14. GLOBAL PULMONARY ARTERIAL HYPERTENSION MARKET: PRICING DETAILS